tiprankstipranks
Trending News
More News >
Tamar Petroleum Ltd. (IL:TMRP)
:TMRP
Israel Market
Advertisement

Tamar Pet (TMRP) AI Stock Analysis

Compare
3 Followers

Top Page

IL:TMRP

Tamar Pet

(TMRP)

Rating:79Outperform
Price Target:
4,964.00
▲(19.61% Upside)
Tamar Pet's stock is rated highly due to strong technical momentum and a solid valuation with a good dividend yield. Financial performance is robust, though high leverage is a concern. The absence of earnings call and corporate events data did not impact the score.

Tamar Pet (TMRP) vs. iShares MSCI Israel ETF (EIS)

Tamar Pet Business Overview & Revenue Model

Company DescriptionTamar Pet (TMRP) is a leading company in the pet care industry, specializing in high-quality pet products and services. The company operates in multiple sectors, including pet food, accessories, and health care, offering a wide range of core products such as premium pet food, toys, grooming supplies, and veterinary services. TMRP is committed to improving the lives of pets and their owners through innovative solutions and exceptional customer service.
How the Company Makes MoneyTamar Pet generates revenue through several key streams. The primary revenue source comes from the sale of pet food and accessories, which includes both in-store and online retail channels. Additionally, the company profits from grooming services and veterinary care, offering bundled packages that encourage customer loyalty. TMRP also engages in partnerships with pet supply retailers and e-commerce platforms, enhancing its distribution reach and visibility. Furthermore, the company explores subscription models for pet food delivery, providing a steady income stream. Seasonal promotions and loyalty programs are significant factors that contribute to repeat business and customer retention.

Tamar Pet Financial Statement Overview

Summary
Tamar Pet demonstrates solid financial performance with strong cash flow generation and improving revenue growth. However, high leverage poses a risk to financial stability, and there is some pressure on profit margins.
Income Statement
75
Positive
Tamar Pet has shown a positive revenue growth rate of 5.74% in the TTM, indicating a recovery from previous declines. The gross profit margin is strong at 42.22%, and the net profit margin is healthy at 17.65%. However, there is a slight decline in margins compared to previous years, suggesting some pressure on profitability.
Balance Sheet
65
Positive
The company has a high debt-to-equity ratio of 1.59, which is a concern for financial stability. However, the return on equity is reasonable at 12.43%, indicating efficient use of equity. The equity ratio is not explicitly calculated, but the high leverage suggests potential risk.
Cash Flow
80
Positive
Tamar Pet's cash flow is robust, with a free cash flow growth rate of 10.83% in the TTM. The operating cash flow to net income ratio is strong at 1.21, and the free cash flow to net income ratio is healthy at 0.62, indicating good cash generation relative to earnings.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue315.18M310.44M234.02M302.19M238.94M253.27M
Gross Profit100.83M110.27M197.19M117.71M100.27M152.47M
EBITDA150.34M157.04M144.99M156.67M129.07M188.80M
Net Income52.74M58.56M49.51M33.82M39.68M88.26M
Balance Sheet
Total Assets1.22B1.22B1.22B1.27B1.28B1.31B
Cash, Cash Equivalents and Short-Term Investments46.24M23.22M32.17M83.06M94.06M92.45M
Total Debt672.09M699.00M751.96M804.30M855.57M931.84M
Total Liabilities789.24M796.47M829.40M903.69M937.55M994.75M
Stockholders Equity434.38M427.78M392.77M362.26M346.16M313.47M
Cash Flow
Free Cash Flow109.64M89.64M47.62M161.65M136.80M168.33M
Operating Cash Flow162.93M156.18M89.70M167.76M139.21M179.45M
Investing Cash Flow-45.34M-47.36M-21.74M-63.65M-4.71M-16.16M
Financing Cash Flow-120.44M-118.30M-116.20M-116.02M-133.28M-154.39M

Tamar Pet Technical Analysis

Technical Analysis Sentiment
Positive
Last Price4150.00
Price Trends
50DMA
4098.93
Positive
100DMA
3823.48
Positive
200DMA
3255.72
Positive
Market Momentum
MACD
34.64
Positive
RSI
54.07
Neutral
STOCH
39.64
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:TMRP, the sentiment is Positive. The current price of 4150 is above the 20-day moving average (MA) of 4102.99, above the 50-day MA of 4098.93, and above the 200-day MA of 3255.72, indicating a bullish trend. The MACD of 34.64 indicates Positive momentum. The RSI at 54.07 is Neutral, neither overbought nor oversold. The STOCH value of 39.64 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:TMRP.

Tamar Pet Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
3.30B19.10
6.68%11.84%-4.96%
65
Neutral
$14.98B7.444.09%5.34%4.10%-61.67%
$5.71B12.5826.44%4.26%
$4.19B16.9210.26%7.04%
4.68B10.55
4.92B17.83
3.51%
* Energy Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:TMRP
Tamar Pet
4,150.00
2,398.20
136.90%
DKDRF
Newmed Energ Pu
4.92
2.52
105.00%
DLKGF
Delek Group
234.30
137.15
141.17%
IL:EQTL
Equital
15,250.00
3,500.00
29.79%
IL:LAPD
Lapidoth Cap.
8,219.00
3,043.77
58.81%

Tamar Pet Corporate Events

Tamar Portfolio Ltd. Schedules Extraordinary Shareholder Meeting
Feb 12, 2025

Tamar Portfolio Ltd. has announced an extraordinary general meeting of shareholders to be held on March 20, 2025, in Herzliya. The meeting’s agenda includes the appointment of an external director and the approval of compensation for directors and officers. Shareholders eligible to vote are those holding shares as of February 1, 2025. The meeting will comply with the relevant Companies Law and Securities Regulations. Any changes to the meeting date will be at the company’s discretion.

Tamar Portfolio Ltd Announces Board Meeting Agenda
Feb 12, 2025

Tamar Portfolio Ltd has announced a board of directors meeting scheduled for March 20, 2025, where the agenda will cover significant topics such as the approval of the financial statements for 2024, discussions on the business plan for 2025 and beyond, and the appointment and remuneration of directors and officers. This meeting underscores the company’s commitment to transparency and open communication with shareholders, as they are invited to attend and engage with the agenda items, highlighting an effort to maintain a strong relationship with its stakeholders.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 25, 2025